The genomic landscape of CYP2D6 variation in the Indian population

被引:0
|
作者
Sivadas, Ambily [1 ]
Rathore, Surabhi [2 ,3 ]
Sahana, S. [2 ,3 ]
Jolly, Bani [2 ,3 ]
Bhoyar, Rahul C. [2 ]
Jain, Abhinav [2 ,3 ]
Sharma, Disha [2 ]
Imran, Mohamed [2 ,3 ]
Senthilvel, Vigneshwar [2 ,3 ]
Divakar, Mohit Kumar [2 ,3 ]
Mishra, Anushree [2 ,3 ]
Sivasubbu, Sridhar [2 ,3 ,4 ]
Scaria, Vinod [2 ,3 ,4 ]
机构
[1] St Johns Natl Acad Hlth Sci, Div Nutr, St Johns Res Inst, Bangalore 560034, Karnataka, India
[2] CSIR, Inst Genom & Integrat Biol, Mathura Rd, New Delhi 110025, India
[3] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, Uttar Pradesh, India
[4] Vishwanath Canc Care Fdn, B 702,7th Floor,Neelkanth Business Pk Kirol Villag, Vidya Vihar 400086, West Mumbai, India
关键词
cytochrome P450; drug metabolism; genomics; Indian population; molecular dynamics simulation; personalized medicine; pharmacogenomics; pharmacology; polymorphism; DRUG-METABOLIZING-ENZYMES; GENETIC-POLYMORPHISM; POOR METABOLIZERS; CRYSTAL-STRUCTURE; IN-SILICO; WILD-TYPE; DEBRISOQUINE; VARIANTS; IDENTIFICATION; FREQUENCY;
D O I
10.2217/pgs-2023-0233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The CYP2D6 gene is highly polymorphic, causing large interindividual variability in the metabolism of several clinically important drugs. Materials & methods: The authors investigated the diversity and distribution of CYP2D6 alleles in Indians using whole genome sequences (N = 1518). Functional consequences were assessed using pathogenicity scores and molecular dynamics simulations. Results: The analysis revealed population-specific CYP2D6 alleles (*86, *7, *111, *112, *113, *99) and remarkable differences in variant and phenotype frequencies with global populations. The authors observed that one in three Indians could benefit from a dose alteration for psychiatric drugs with accurate CYP2D6 phenotyping. Molecular dynamics simulations revealed large conformational fluctuations, confirming the predicted reduced function of *86 and *113 alleles. Conclusion: The findings emphasize the utility of comprehensive CYP2D6 profiling for aiding precision public health.
引用
收藏
页码:147 / 160
页数:14
相关论文
共 50 条
  • [41] Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes
    Lundqvist, E
    Johansson, I
    Ingelman-Sundberg, M
    GENE, 1999, 226 (02) : 327 - 338
  • [42] Characterization of CYP2D6 Pharmacogenetic Variation in Sub-Saharan African Populations
    Twesigomwe, David
    Drogemoller, Britt, I
    Wright, Galen E. B.
    Adebamowo, Clement
    Agongo, Godfred
    Boua, Palwende R.
    Matshaba, Mogomotsi
    Paximadis, Maria
    Ramsay, Michele
    Simo, Gustave
    Simuunza, Martin C.
    Tiemessen, Caroline T.
    Lombard, Zane
    Hazelhurst, Scott
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) : 643 - 659
  • [43] Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
    Sistonen, Johanna
    Fuselli, Silvia
    Palo, Jukka U.
    Chauhan, Neelam
    Padh, Harish
    Sajantila, Antti
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (02) : 170 - 179
  • [44] Effects of CYP2D6*4 Polymorphism in the Developmet of Ploygenetic Diseases in Chechen Poplulation
    Bisultanova, Z. I.
    Molochaeva, L. G.
    Dzhambetova, P. M.
    Atsayeva, Maret M.
    Machigov, Elbek A.
    Plieva, Aishet M.
    PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ENGINEERING AND EARTH SCIENCES: APPLIED AND FUNDAMENTAL RESEARCH (ISEES 2018), 2018, 177 : 133 - 136
  • [45] Prevalence of CYP2D6 structural variation in large retrospective study
    Frear, Samantha
    Sherman, Ashley
    Rule, Don
    Marcath, Lauren Ann
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (04) : 135 - 138
  • [46] Comparing feature selection and machine learning approaches for predicting CYP2D6 methylation from genetic variation
    Fong, Wei Jing
    Tan, Hong Ming
    Garg, Rishabh
    Teh, Ai Ling
    Pan, Hong
    Gupta, Varsha
    Krishna, Bernadus
    Chen, Zou Hui
    Purwanto, Natania Yovela
    Yap, Fabian
    Tan, Kok Hian
    Chan, Kok Yen Jerry
    Chan, Shiao-Yng
    Goh, Nicole
    Rane, Nikita
    Tan, Ethel Siew Ee
    Jiang, Yuheng
    Han, Mei
    Meaney, Michael
    Wang, Dennis
    Keppo, Jussi
    Tan, Geoffrey Chern-Yee
    FRONTIERS IN NEUROINFORMATICS, 2024, 17
  • [47] CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction
    Gaedigk, Andrea
    Fuhr, Uwe
    Johnson, Charlene
    Berard, L. Anick
    Bradford, DiAnne
    Leeder, J. Steven
    PHARMACOGENOMICS, 2010, 11 (01) : 43 - 53
  • [48] Influence of CYP2D6 genetic variation on adverse events with propafenone in the pediatric and young adult population
    Sunthankar, Sudeep D.
    Kannankeril, Prince J.
    Gaedigk, Andrea
    Radbill, Andrew E.
    Fish, Frank A.
    Van Driest, Sara L.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (07): : 1787 - 1795
  • [49] Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population
    Isaza, CA
    Henao, J
    López, AM
    Cacabelos, R
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2000, 22 (09): : 695 - 705
  • [50] Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
    Charoenchokthavee, Wanaporn
    Panomvana, Duangchit
    Sriuranpong, Virote
    Areepium, Nutthada
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 149 - 155